Upregulation of let-7a inhibits vascular smooth muscle cell proliferation in vitro and in vein graft intimal hyperplasia in rats

Journal of Surgical Research

Volumn 192, Issue 1, 2014, Pages 223-233

  Cao, Hui ^a   Hu, Xinhua ^a   Zhang, Qiang ^a   Wang, Junpeng ^a   Li, Jun ^a   Liu, Bing ^a   Shao, Yang ^a   Li, Xi ^a   Zhang, Jian ^a   Xin, Shijie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Intimal hyperplasia; Let 7a; Proliferation; Vascular smooth muscle cells; Vein graft

Indexed keywords

CYCLINE; K RAS PROTEIN; LENTIVIRUS VECTOR; MICRORNA; MICRORNA 21; MICRORNA 299; MICRORNA LET7A; MYC PROTEIN; PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG; MIRNLET7 MICRORNA, RAT; PLATELET DERIVED GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTIMAL HYPERPLASIA; MALE; MICROARRAY ANALYSIS; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE; VEIN GRAFT; WESTERN BLOTTING; ANIMAL; CELL MOTION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; GRAFT OCCLUSION; GRAFT SURVIVAL; INTIMA; JUGULAR VEIN; METABOLISM; ONCOGENE MYC; ONCOGENE RAS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SURGERY;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENES, MYC; GENES, RAS; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; JUGULAR VEINS; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA; UP-REGULATION;

EID: 84921809796     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.05.045     Document Type: Article

References (49)

1. Heaton NS, Wolff RA, Malinowski RL, et al. Antisense to transforming growth factor-beta (1) facilitates the apoptosis of macrophages in rat vein grafts. J Vasc Res 2008;45:365.
2. Sun J, Zheng J, Ling KH, et al. Preventing intimal thickening of vein grafts in vein artery bypass using STATA-3 siRNA. J Transl Med 2012;10:2.
3. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 2005;294:2446.
4. Muto A, Panitch A, Kim N, et al. Inhibition of mitogen activated protein kinase activated protein kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. Vascul Pharmacol 2012;56:47.
5. Conte MS, Bandyk DF, Clowes AW, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006;43:742.
6. Harskamp RE, Lopes RD, Baisden CE, et al. Saphenous vein graft failure after coronary artery bypass surgery. Ann Surg 2013;257:824.
7. WallittEJ, JevonM, HornickPI.Therapeuticsofveingraft intimal hyperplasia: 100 years on. Ann Thorac Surg 2007;84:317.
8. Zou J, Zhang X, Yang H, et al. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts. J Cardiothorac Surg 2011;6:69.
9. Mehta D, George SJ, Jeremy JY, et al. External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med 1998;4:235.
10. Kim SY, Jeoung NH, Oh CJ, et al. Activation of NAD(P)H: quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. Circ Res 2009;104:842.
11. Vogt F, Zernecke A, Beckner M, et al. Blockade of angioassociated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis. J Am Coll Cardiol 2008;52:302.
12. Rokah OH, Granot G, Ovcharenko A, et al. Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PloS one 2012;7:e35501.
13. Zimmerman AL, Wu S. MicroRNAs, cancer and cancer stem cells. Cancer Lett 2011;300:10.
14. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281.
15. van Rooij E. The art ofmicroRNAresearch.Circ Res 2011;108:219.
16. van Rooij E. Introduction to the series on microRNAs in the cardiovascular system. Circ Res 2012;110:481.
17. Esquela-Kerscher A, Slack FJ. OncomiRs - microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259.
18. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007;6:60.
19. Asli NS, Pitulescu ME, Kessel M. MicroRNAs in organogenesis and disease. Curr Mol Med 2008;8:698.
20. Gartel AL, Kandel ES. miRNAs: little known mediators of oncogenesis. Semin Cancer Biol 2008;18:103.
21. Ji R, Cheng Y, Yue J, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579.
22. Diao Y, Xue J, Segal MS. A novel mouse model of autologous venous graft intimal hyperplasia. J Surg Res 2005;126:106.
23. Liu X, Cheng Y, Zhang S, et al. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009;104:476.
24. Yin M, Zhang J, Wang Y, et al. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2010;30:1825.
25. SunDX, LiuZ, TanXD, et al.Nanoparticle-mediated local delivery of an antisense TGF-b1 construct inhibits intimal hyperplasia in autogenous vein grafts in rats. PLoS One 2012;7:e41857.
26. Brown C, Pan X, Hassid A. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. Circ Res 1999;84:655.
27. Yu ML, Wang JF, Wang GK, et al. Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS. Circ J 2011;75:703.
28. Chang X, Li Z, Ma J, et al. DNA methylation of NDRG2 in gastric cancer and its clinical significance. Dig Dis Sci 2013;58:715.
29. Li F, Duman-Scheel M, Yang D, et al. Sonic hedgehog signaling induces vascular smooth muscle cell proliferation via induction of the G1 cyclin-retinoblastoma axis. Arterioscler Thromb Vasc Biol 2010;30:1787.
30. Cheng J, Du J. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor. Arterioscler Thromb Vasc Biol 2007;27:1744.
31. Stojanovic T, El-Sayed Ahmad A, Didilis V, et al. Extravascular perivenous fibrin support leads to aneurysmal degeneration and intimal hyperplasia in arterialized vein grafts in the rat. Langenbecks Arch Surg 2009;394:357.
32. Kloppenburg GT, de Graaf R, Grauls GE, et al. Chlamydia pneumoniae aggravates vein graft intimal hyperplasia in a rat model. BMC Microbiol 2007;7:111.
33. Kloppenburg GT, Grauls GE, Bruggeman CA, et al. Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model. Interact Cardiovasc Thorac Surg 2009;8:31.
34. Ylä -Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003;9:694.
35. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000;403:901.
36. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753.
37. Johnson CD, Esquela-Kerscher A, Stefani G, et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007;67:7713.
38. Wang M, Li W, Chang GQ, et al. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol 2011;31:2044.
39. Li P, Liu Y, Yi B, et al. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BBinduced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res 2013;99:185.
40. Karshovska E, Zernecke A, Sevilmis G, et al. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2007;27:2540.
41. Liu Y, Yin B, Zhang C, et al. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting cmyc. Biochem Bophys Res Commu 2012;417:371.
42. He XY, Chen JX, Zhang Z, et al. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J Cancer Res Clin Oncol 2010;136:1023.
43. Sampson VB, Rong NH, Han J, et al. MicroRNA let-7a downregulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007;67:9762.
44. Khodayari N, Mohammed KA, Goldberg EP, et al. Ephrina1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene. Cancer Gene Ther 2011;18:806.
45. Bennett MR, Littlewood TD, Hancock DC, et al. Downregulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest? Biochem J 1994;302(Pt 3):701.
46. Wang J, Liu K, Shen L, et al. Small interfering RNA to c-myc inhibits vein graft restenosis in a rat vein graft model. J Surg Res 2011;169:e85.
47. Kuehbacher A, Urbich C, Zeiher AM, et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007;101:59.
48. Halka AT, Turner NJ, Carter A, et al. The effects of stretch on vascular smooth muscle cell phenotype in vitro. Cardiovasc Pathol 2008;17:98.
49. Torella D, Iaconetti C, Catalucci D, et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011; 109:880.